The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
Abstract
Natural products represent a rich reservoir of potential small chemical molecules exhibiting antiproliferation and anticancer properties. An example is berberine, a protoberberine alkaloid widely distributed in medical plants used in traditional Chinese prescriptions. Recent advances have shown that berberine exerts anticancer activities both in vitro and in vivo through different mechanisms. Berberine shows inhibitory effects on the proliferation and reproduction of certain tumorigenic microorganisms and viruses, such as Heliobacter pylori and hepatitis B virus. Transcriptional regulation of some oncogene and carcinogenesis-related gene expression and interaction with both DNA and RNA are also well documented. Besides, berberine is a broad spectrum enzyme inhibitor, which affects N-acetyltransferase, cyclooxygenase-2, and topoisomerase activities and gene/protein expression. These actions, together with the regulation of reactive oxygen species production, mitochondrial transmembrane potential, and nuclear factor-kappaB activation might underlie its antiproliferative and proapoptotic effects. More importantly, the suppression of tumor growth and metastasis, the beneficial application in combined medication, and the improvement of multidrug resistance both in vivo and in vitro clearly show its potential as an alternative medicine for tumor chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl043 · Cited by 174
RetractedABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Irani, K. (2000) · Circulation Research · doi:10.1161/01.res.87.3.179 · Cited by 748
Telomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
The anti-inflammatory potential of berberine in vitro and in vivo
Kuo, C.-L., Chi, C.-W., & Liu, T.-Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.09.002 · Cited by 685
N-acetylation pharmacogenetics.
Weber, W. W., & Hein, D. W. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06816-4 · Cited by 648
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Imanshahidi, M., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2399 · Cited by 634
Natural products in anticancer therapy
da Rocha, A. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00063-7 · Cited by 604
Mantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0448 · Cited by 353
Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00162-7 · Cited by 270
Romero, M. R., Efferth, T., Serrano, M. A., Castaño, B., Macias, R. I. R., Briz, O., & Marin, J. J. G. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.07.005 · Cited by 233
Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells
Hwang, J. M., Kuo, H. C., Tseng, T. H., Liu, J. Y., & Chu, C. Y. (2006) · Archives of Toxicology · doi:10.1007/s00204-005-0014-8 · Cited by 204
Pandey, M. K., Sung, B., Kunnumakkara, A. B., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0511 · Cited by 200
Letašiová, S., Jantová, S., Čipák, L., & Múčková, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.08.024 · Cited by 189
Meeran, S. M., Katiyar, S., & Katiyar, S. K. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.027 · Cited by 184
Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells
Kuo, C. L., Chou, C. C., & Yung, B. Y.-M. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03809-b · Cited by 177
Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells
Jantová, S., čipák, L., čerňáková, M., & Košt‘álová, D. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235703322277186 · Cited by 176
Cyclo‐oxygenase‐2 Plays a Critical Role in UV‐induced Skin Carcinogenesis†
Rundhaug, J. E., & Fischer, S. M. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00261.x · Cited by 173
Targeting telomerase for cancer therapeutics
Shay, J. W., & Keith, W. N. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604209 · Cited by 171
Ho, Y.-T., Yang, J., Li, T., Lin, J., Lin, J., Lai, K., Ma, C.-Y., Wood, W. G., & Chung, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.033 · Cited by 170
Iizuka, N., Miyamoto, K., Okita, K., Tangoku, A., Hayashi, H., Yosino, S., Abe, T., Morioka, T., Hazama, S., & Oka, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00264-5 · Cited by 170
Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line
Lin, J.-P., Yang, J.-S., Lee, J.-H., Hsieh, W.-T., & Chung, J.-G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i1.21 · Cited by 159
Inhibition of chemical carcinogenesis by berberine in rats and mice
Anis, K. V., Rajeshkumar, N. V., & Kuttan, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775901 · Cited by 159
Hsu, W.-H., Hsieh, Y.-S., Kuo, H.-C., Teng, C.-Y., Huang, H.-I., Wang, C.-J., Yang, S.-F., Liou, Y.-S., & Kuo, W.-H. (2007) · Archives of Toxicology · doi:10.1007/s00204-006-0169-y · Cited by 159
Hu, J.-P., Nishishita, K., Sakai, E., Yoshida, H., Kato, Y., Tsukuba, T., & Okamoto, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.013 · Cited by 156
Peng, P.-L., Hsieh, Y., Wang, C., Hsu, J., & Chou, F. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.11.010 · Cited by 155
Pereira, G. C., Branco, A. F., Matos, J. A. C., Pereira, S. L., Parke, D., Perkins, E. L., Serafim, T. L., Sardão, V. A., Santos, M. S., Moreno, A. J. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128017 · Cited by 152
Katiyar, S. K., Meeran, S. M., Katiyar, N., & Akhtar, S. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20453 · Cited by 148
Inhibitory effect of berberine on tert -butyl hydroperoxide-induced oxidative damage in rat liver
Hwang, J.-M., Wang, C., Chou, F.-P., Tseng, T., Hsieh, Y., Lin, W., & Chu, C.-Y. (2002) · Archives of Toxicology · doi:10.1007/s00204-002-0351-9 · Cited by 146
Serafim, T. L., Oliveira, P. J., Sardão, V. A., Perkins, E., Parke, D., & Holy, J. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0558-9 · Cited by 142
Liu, Z., Liu, Q., Xu, B., Wu, J., Guo, C. H., Zhu, F., Yang, Q., Gao, G., Gong, Y., & Shao, C. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.009 · Cited by 140
Peng, P.-L., Kuo, W., Tseng, H., & Chou, F. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.034 · Cited by 139
Lin, C., Ng, L., Hsu, F.-F., Shieh, D., & Chiang, L. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.03951.x · Cited by 132
Lee, C.-H., Chen, J., Hsiang, C., Wu, S., Wu, H.-C., & Ho, T. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.06.003 · Cited by 129
Back to the Future: COX-2 Inhibitors for Chemoprevention and Cancer Therapy
Sarkar, F. H., Adsule, S., Li, Y., & Padhyé, S. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707780859431 · Cited by 127
The role of cyclooxygenase-2 in breast cancer: review
Singh‐Ranger, G., Salhab, M., & Mokbel, K. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9641-5 · Cited by 126
Vasorelaxant and antiproliferative effects of berberine
Ko, W. H., Yao, X., Lau, C., Law, W.-I., Chen, Z., Kwok, W., Ho, W. K. K., & Huang, Y. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00339-3 · Cited by 121
Targeted induction of apoptosis for cancer therapy: current progress and prospects
Bremer, E., van Dam, G., Kroesen, B. J., de Leij, L., & Helfrich, W. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.06.002 · Cited by 121
Berberine inhibits HIF-1alpha expression via enhanced proteolysis.
Lin, S., Tsai, S.-C., Lee, C.-C., Wang, B.-W., Liou, J.-Y., & Shyu, K. (2004) · PubMed · Cited by 119
Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells
Hồng (2009) · International Journal of Oncology · doi:10.3892/ijo_00000250 · Cited by 114
Inhibition of Activator Protein 1 Activity by Berberine in Human Hepatoma Cells
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. (1999) · Planta Medica · doi:10.1055/s-2006-960795 · Cited by 112
Rojsanga, P., Sukhthankar, M., Gritsanapan, W., & Baek, S. J. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.09.007 · Cited by 112
Choi, M. S., Oh, J. H., Kim, S. M., Jung, H. Y., Yoo, H. S., Lee, Y., Moon, D. C., Han, S., & Hong, J. T. (2009) · PubMed · Cited by 110
Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells
Jantová, S., Čipák, L., & Letašiová, S. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.07.015 · Cited by 107
Liu, W., Hei, Z., Nie, H., Tang, F., Huang, H., Li, X., Yan-hui, D. E. N. G., Chen, S., Guo, F., Huang, W., et al. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200804020-00009 · Cited by 105
Li, X.-K., Motwani, M., Tong, W. P., Bornmann, W. G., & Schwartz, G. K. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12699-5 · Cited by 105
Induction of Topoisomerase II-Mediated DNA Cleavage by a Protoberberine Alkaloid, Berberrubine
Kim, S. A., Kwon, Y. V., Kim, J. H., Muller, M. T., & Chung, I. K. (1998) · Biochemistry · doi:10.1021/bi9810961 · Cited by 104
ABCG transporters: structure, substrate specificities and physiological roles
Velamakanni, S., Wei, S. L., Janvilisri, T., & van Veen, H. W. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9122-x · Cited by 103
Hsieh, Y., Kuo, W., Lin, T.-W., Chang, H., Lin, T.-H., Chen, P., & Chu, S. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071868c · Cited by 103
Lin, H.-L., Liu, T.-Y., Wu, C.-W., & Chi, C.-W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690710 · Cited by 100
Biochemical effects of berberine
Creasey, W. A. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90308-3 · Cited by 97
Wang, X.-N., Han, X., Xu, L., Yin, L.-H., Xu, Y., Qi, Y., & Peng, J. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.05.002 · Cited by 96
Regulation of Nrf2, NF-κB, and AP-1 Signaling Pathways by Chemopreventive Agents
Shen, G., Jeong, W., Hu, R., & Kong, A. T. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1648 · Cited by 95
Lin, T., Kuo, H., Chou, F., & Lu, F. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-58 · Cited by 95
Lin, C. C., Lin, S. Y., Chung, J., Lin, J., Chen, G. W., & Kao, S. T. (2006) · PubMed · Cited by 93
Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes
Kim, S.-M., Kim, Y., Kim, J. E., Cho, K. H., & Chung, J. H. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.09.011 · Cited by 92
Wartenberg, M., Wolf, S., Budde, P., Grünheck, F., Acker, H., Hescheler, J., Wartenberg, G., & Sauer, H. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000098424.38003.ff · Cited by 92
Thirupurasundari, C. J., PADMINI, R., & Devaraj, S. N. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.09.027 · Cited by 91
Liu, W., Liu, P., Tao, S., Deng, Y., Li, X., Lan, T., Zhang, X., Guo, F., Huang, W., Chen, F., et al. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.022 · Cited by 91
Liang, K., Yin, S., Ting, C.-T., Lin, S., Hsueh, C., Chen, C.-Y., & Hsu, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.034 · Cited by 89
Yokozawa, T., Ishida, A., Cho, E. J., Kim, H. Y., Kashiwada, Y., & Ikeshiro, Y. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023024 · Cited by 88
Lin, C. C., Kao, S. T., Chen, G. W., Ho, H.-C., & Chung, J. (2006) · PubMed · Cited by 83
Wartenberg, M., Budde, P., de Marées, M., Grünheck, F., Tsang, S. Y., Huang, Y., Chen, Z., Hescheler, J., & Sauer, H. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000049348.51663.2f · Cited by 83
Effects of Berberine on Arylamine N-Acetyltransferase Activity in Human Colon Tumor Cells
Lin, J.-Y., Chung, J., Wu, L., Chen, G. W., Chang, H. L., & Wang, T. F. (1999) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x99000306 · Cited by 83
Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model
Ho, Y.-T., Yang, J., Lu, C., et al. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.02.015 · Cited by 83
Eom, K., Hong, J.-M., Youn, M., So, H., Park, R., Kim, J., & Kim, T. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.558 · Cited by 83
Mitani, N., Murakami, K., Yamaura, T., Ikeda, T., & Saiki, I. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00710-2 · Cited by 83
Farinati, F., Cardin, R., Cassaro, M., Bortolami, M., Nitti, D., Tieppo, C., Zaninotto, G., & Rugge, M. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282f0bff5 · Cited by 82
Berberine–DNA complexation: New insights into the cooperative binding and energetic aspects
Bhadra, K., Maiti, M., & Kumar, G. S. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.05.005 · Cited by 81
Hydroxyl radical scavenging activities of isoquinoline alkaloids isolated from Coptis chinensis
Jang, M. H., Kim, H. Y., Kang, K. S., Yokozawa, T., & Park, J. H. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1305-z · Cited by 81
Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis.
Choi, M. S., Yuk, D. Y., Oh, J. H., Jung, H. Y., Han, S., Moon, D. C., & Hong, J. T. (2008) · PubMed · Cited by 80
Liu, J., He, C., Zhou, K., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.169 · Cited by 80
Sakai, K. (2002) · Journal of Experimental Botany · doi:10.1093/jxb/erf052 · Cited by 78
Choi (2009) · International Journal of Oncology · doi:10.3892/ijo_00000234 · Cited by 77
Lee, S., Lim, H., Park, H., Lee, K., Park, J., & Jang, Y. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.048 · Cited by 76
Alkaloids from Corydalis saxicola and Their Anti‐Hepatitis B Virus Activity
Li, H., Han, T., Liu, R., Zhang, C., Chen, H., & Zhang, W. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890074 · Cited by 75
Enk, R., Ehehalt, R., Graham, J. E., Bierhaus, A., Remppis, A., & Greten, H. J. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.07.013 · Cited by 73
Weber, H. A., Zart, M. K., Hodges, A. E., Molloy, H. M., O'Brien, B. M., Moody, L. A., Clark, A. P., Harris, R. K., Overstreet, J. D., & Smith, C. S. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034339r · Cited by 73
Nishino, H., Kitagawa, K., Fujiki, H., & Iwashima, A. (2009) · Oncology · doi:10.1159/000226349 · Cited by 72
Berberine Inhibits HIF-1α Expression via Enhanced Proteolysis
Lin, S., Tsai, S.-C., Lee, C.-C., Wang, B.-W., Liou, J.-Y., & Shyu, K. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05644-x · Cited by 70
Stage specificity of Plasmodium falciparum telomerase and its inhibition by berberine
Sriwilaijareon, N., Petmitr, S., Mutirangura, A., Ponglikitmongkol, M., & Wilairat, P. (2002) · Parasitology International · doi:10.1016/s1383-5769(01)00092-7 · Cited by 69
Iizuka, N., Miyamoto, K., Hazama, S., Yoshino, S., Yoshimura, K., Okita, K., Fukumoto, T., Yamamoto, S., Tangoku, A., & Oka, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00496-1 · Cited by 67
Hyaluronan, CD44, and Cyclooxygenase-2 in Colon Cancer
Misra, S., Hascall, V. C., Berger, F. G., Markwald, R. R., & Ghatak, S. (2008) · Connective Tissue Research · doi:10.1080/03008200802143356 · Cited by 63
Zhang, R. X., Dougherty, D. V., & Rosenblum, M. L. (1990) · PubMed · Cited by 63
Chi, C., Chang, Y., Chao, T., Chiang, S., P’eng, F., Lui, W., & Liu, T. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00719-5 · Cited by 62
Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
Gallego, G. A., Díaz‐Prado, S., Fonseca, P. J., Campelo, R. G., Espinosa, J., & Aparicio, L. M. A. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0126-0 · Cited by 62
Yokozawa, T., Satoh, A., Cho, E. J., Kashiwada, Y., & Ikeshiro, Y. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055470 · Cited by 61
Iizuka, N., Hazama, S., Yoshimura, K., Yoshino, S., Tangoku, A., Miyamoto, K., Okita, K., & Oka, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10338 · Cited by 59
Kim, S., & Chung, J. H. (2008) · Phytomedicine · doi:10.1016/j.phymed.2007.11.004 · Cited by 57
Tan, Y. H., Tang, Q., Hu, B., et al. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00705.x · Cited by 57
Sethi, M. L. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720515 · Cited by 57
Lin, H.-L., Liu, T., Lui, W., & Chi, C. (1999) · Cancer · Cited by 57
Inhibition of Topoisomerase I Function by Coralyne and 5,6-Dihydrocoralyne
Wang, L., Rogers, B. D., & Hecht, S. M. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950080y · Cited by 55
Letašiová, S., Jantová, S., Miko, M., Ovádeková, R., & Horváthová, M. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.2.0015 · Cited by 54
Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro
Orfila, L., Rodrı́guez, M., Colman, T., Hasegawa, M., Merentes, E., & Arvelo, F. A. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00177-x · Cited by 54
Jantová, S., Letašiová, S., Brezová, V., et al. (2006) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2006.07.001 · Cited by 51
Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells
Yang, I. W., Chou, C. C., & Yung, B. Y. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178709 · Cited by 50
Wu, S., Yu, H., Jan, C., Li, H.-F., & Yu, C.-L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00209-4 · Cited by 45
Jagetia, G. C., & Baliga, M. S. (2004) · Journal of Medicinal Food · doi:10.1089/1096620041224094 · Cited by 44
Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model
Kettmann, V., Košťálová, D., & Höltje, H. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-004-7878-1 · Cited by 43
Kang, M. R., & Chung, I. K. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12339-5 · Cited by 42
Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer
Ichiki, K., Mitani, N., Doki, Y., Hara, H., Misaki, T., & Saiki, I. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1011980313237 · Cited by 41
Regulation of Arylamine N-Acetyltransferases
Butcher, N. J., Tiang, J. M., & Minchin, R. F. (2008) · Current Drug Metabolism · doi:10.2174/138920008784892128 · Cited by 41
Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.
Yount, G. L., Qian, Y., Moore, D. H., Basila, D., West, J. M., Aldape, K., Arvold, N. D., Shalev, N., & Haas-Kogan, D. A. (2004) · PubMed · Cited by 34
Liu, S., Sun, Y., Tian, D., He, Y., Zeng, L., He, Y., Ling, C., & Sun, S. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604167 · Cited by 34
Self-citationLin, S., Chung, J., LIN, J.-G., Chuang, J., CHANG, W.-J., Wu, J. Y., & Tyan, Y. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.11.008 · Cited by 34
Issat, T., Jakóbisiak, M., & Gołąb, J. (2006) · Oncology Reports · doi:10.3892/or.16.6.1273 · Cited by 33
Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas.
Wang, L.-C., Vass, W. C., Gao, C., & Chang, K. S. S. (1987) · PubMed · Cited by 33
Chung, J., Chen, G. W., Hung, C. F., et al. (2000) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x00000271 · Cited by 28
[Anti-blastic properties of berberine and its derivatives].
Shvarev, I. F., & Tsetlin, A. L. (1972) · PubMed · Cited by 8
Cited by
Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02198-8 · Cited by 565
The metabolism of berberine and its contribution to the pharmacological effects
Wang, K., Feng, X., Chai, L., Cao, S., & Qiu, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1306544 · Cited by 502
Berberine: New perspectives for old remedies
Tillhon, M., Guamán Ortiz, L. M., Lombardi, P., & Scovassi, A. I. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.018 · Cited by 477
Alkaloids Isolated from Natural Herbs as the Anticancer Agents
Lu, J.-J., Bao, J.-L., Chen, X.-P., Huang, M., & Wang, Y.-T. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/485042 · Cited by 384
Self-citationZou, K., Li, Z., Zhang, Y., Zhang, H.-Y., Li, B., Zhu, W.-L., Shi, J.-Y., Jia, Q., & Li, Y.-M. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.125 · Cited by 317
Metadata
- Authors
- Sun, Y., Xun, K., Wang, Y., & Chen, X.
- Venue
- Anti-Cancer Drugs
- Published
- 2009-10
- Volume
- 20
- Issue
- 9
- Pages
- 757-769
- ISSN
- 0959-4973 (ISSN-L)
- OpenAlex
- W2171918265
- Cited by
- 417
- References
- 111
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.